Klinikum Kassel GmbH

Hospital


Location: Kassel, Germany (DE) DE

ISNI: 0000000406253279

ROR: https://ror.org/048ycfv73

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Decompressive craniectomy plus best medical treatment versus best medical treatment alone for spontaneous severe deep supratentorial intracerebral haemorrhage: a randomised controlled clinical trial (2024) Beck J, Fung C, Strbian D, Bütikofer L, Z'Graggen WJ, Lang MF, Beyeler S, et al. Journal article Multicenter evaluation of an automated, multiplex, RNA-based molecular assay for detection of ALK, ROS1, RET fusions and MET exon 14 skipping in NSCLC (2024) Melchior L, Hirschmann A, Hofman P, Bontoux C, Concha A, Mrabet-Dahbi S, Vannuffel P, et al. Journal article Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputation (2024) Böhm S, Wustrau K, Pachlopnik Schmid J, Prader S, Ahlmann M, Yacobovich J, Beier R, et al. Journal article Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy: A Nonrandomized Controlled Trial (2024) Schwartz O, Vill K, Pfaffenlehner M, Behrens M, Weiß C, Johannsen J, Friese J, et al. Journal article Correction to: Multicenter evaluation of an automated, multiplex, RNA-based molecular assay for detection of ALK, ROS1, RET fusions and MET exon 14 skipping in NSCLC (Virchows Archiv, (2024), 10.1007/s00428-024-03778-9) (2024) Melchior L, Hirschmann A, Hofman P, Bontoux C, Concha A, Mrabet‑Dahbi S, Vannuffel P, et al. Journal article, Erratum Inferred Immune-Cell Activity Is an Independent Predictor of HER2-Negative Breast Cancer Prognosis and Response to Paclitaxel-Based Therapy in the GeparSepto Trial (2023) Fasching P, Szeto C, Denkert C, Benz S, Weber K, Spilman P, Budczies J, et al. Journal article ETOPOSIDE FOR PRIMARY HLH - BETTER THAN ITS REPUTATION (2023) Lehmberg K, Ledig S, Wustrau K, Kontny U, Westphal S, Hundsdoerfer P, Jorch N, et al. Conference contribution Newbornscreening SMA - From Pilot Project to Nationwide Screening in Germany (2023) Müller-Felber W, Blaschek A, Schwartz O, Gläser D, Nennstiel U, Brockow I, Wirth B, et al. Journal article Improvements in Walking Distance during Nusinersen Treatment - A Prospective 3-year SMArtCARE Registry Study (2023) Pechmann A, Behrens M, Dörnbrack K, Tassoni A, Wenzel F, Stein S, Vogt S, et al. Journal article Relationship between age at initiation of cysteamine treatment, adherence with therapy, and glomerular kidney function in infantile nephropathic cystinosis (2022) Nießl C, Boulesteix AL, Oh J, Palm K, Schlingmann P, Wygoda S, Haffner D, et al. Journal article
1 2 3 4